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Validation of a risk prediction tool for
coronary heart disease in middle-aged
women
Katerina M. De Vito1,2, Heather J. Baer1,3*, Hank Dart5, Stephanie E. Chiuve2,6, Eric B. Rimm2,3,4,7
and Graham A. Colditz5

Abstract
Background: Health risk appraisal tools may be useful for identifying individuals who would benefit from lifestyle
changes and increased surveillance. We evaluated the validity of the Your Disease Risk tool (YDR) for estimating
relative risk of coronary heart disease (CHD) among middle-aged women.
Methods: We included 55,802 women in the Nurses’ Health Study who completed a mailed questionnaire about
risk factors in 1994 and had no history of heart disease at that time. Participants were followed through 2004 for
the occurrence of CHD. We estimated each woman’s 10-year relative risk of CHD using YDR, and we compared the
estimated YDR relative risk category (ranging from “very much below average” to “very much above average”) to
the observed relative risk for each category using logistic regression. We also examined the discriminatory accuracy
of YDR using concordance statistics (c-statistics).
Results: There were 1165 CHD events during the 10-year follow-up period. Compared to the “about
average” category, the observed age-adjusted relative risk was 0.43 (95 % confidence interval: 0.33, 0.56)
for the “very much below average” category and 2.48 (95 % confidence interval: 1.68, 3.67) for the “very
much above average” category. The age-adjusted c-statistic for the model including the YDR relative risk
category was 0.71 (95 % confidence interval: 0.69, 0.72). The model performed better in younger than
older women.
Conclusion: The YDR tool appears to have moderate validity for estimating 10-year relative risk of CHD in this
population of middle-aged women. Further research should aim to improve the tool’s performance and to examine its
validity in other populations.
Keywords: Coronary heart disease, Women, Risk assessment

Background
Coronary heart disease (CHD) is the leading cause of
death in the United States, and rates continue to rise
globally [1]. Many modifiable risk factors contribute
to CHD incidence [2], and recent studies indicate
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that lifestyle factors may be the cause of the majority
of CHD cases. The identification of individuals at
high risk, who are most likely to benefit from lifestyle changes and increased surveillance, is important to decreasing morbidity and mortality from
CHD.
Health risk appraisal tools may be useful for
identifying individuals at increased risk and determining appropriate target populations for interventions
[1–3]. Several risk prediction tools for CHD and
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cardiovascular disease (CVD) have been developed,
such as the Framingham Risk Score and the PRECARD and PROCAM Risk Scores [4–13]. These
tools, however, focus primarily on traditional clinical
risk factors for CHD, utilize information that is not
easily accessible to patients, and do not incorporate
information on diet or physical activity, which are important risk factors for CHD [5–13].
Your Disease Risk (YDR) is a publicly-available,
web-based tool (www.yourdiseaserisk.wustl.edu) that
was designed to estimate risk of CHD and other
chronic diseases [5]. Based on self-reported information on lifestyle and clinical risk factors, YDR estimates an individual’s relative risk of developing CHD
over the next 10 years, compared to an average person of the same age and sex [5, 14]. Although the
YDR risk assessment tool for CHD has been available
on the Internet since 2004, it has not been formally
evaluated. Given that this tool may be used by a large
number of patients and clinicians for assessing and
communicating about CHD risk, we feel that it is
critical to examine its validity and to provide this information to the public. Therefore, the purpose of
this study was to examine the validity of YDR for
predicting relative risk of CHD among middle-aged
women, using prospectively-collected data from the
Nurses’ Health Study (NHS).

Methods
Study design and population

The NHS is a prospective cohort study that began in
1976, when 121,700 U.S. female registered nurses between ages 30 and 55 completed a mailed questionnaire about their lifestyle factors, health behaviors,
and medical histories. Follow-up questionnaires have
been sent to participants every 2 years since enrollment to update this information. Dietary factors
were first assessed in 1980 and are updated every
4 years using a food frequency questionnaire [15].
The Institutional Review Board at Brigham and
Women’s Hospital approved this study and considered completion of the questionnaires to be informed consent.
In this analysis, we included women who were alive
in 1994 and completed the 1994 questionnaire. We
chose 1994 through 2004 as the follow-up period for
this analysis due to the availability of risk factor
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information as well as the age distribution of NHS
participants; this allowed us to evaluate the performance of the YDR model in middle-aged and older
women. We excluded women who had a history of
myocardial infarction, coronary artery bypass surgery,
or heart failure before 1994 (n = 37,085). We also excluded participants who missed 10 or more items on
the 1994 food frequency questionnaire, reported eating less than 500 or more than 3500 kilocalories a
day, or had missing data on any of the YDR risk factors (n = 9731). A total of 55,802 women were included in the final study population.

Your Disease Risk Tool

The YDR tool for CHD was developed by a panel of
epidemiologists, clinicians, and other experts from
the medical community according to methods used
to achieve consensus and risk classification for cancer over an extended period of time [5]. These
methods were first used to develop the Harvard
Cancer Risk Index, and are explained in detail in a
report by Colditz et al [5]. The panel generated a list
of genetic, environmental, nutritional, and lifestyle
risk factors that are known causes of CHD or associated with CHD. Next, using the International Agency
for Research on Cancer (IARC) classification approach, they classified the risk factors as “definite”,
“probable”, and “possible” risk factors for CHD and
assigned a magnitude of association for each factor
[5, 16]. Prevalences for the risk factors in the U.S.
population were estimated using many different
sources, including data from the Centers for Disease
Control’s Behavioral Risk Factor Surveillance System
(BRFSS) [17] and the National Health and Nutrition
Examination Survey (NHANES) [18]. Risk factors
assessed in the YDR tool are body mass index (BMI)
(for those <60 years old) and waist circumference
(for those ≥60 years old), smoking history, exposure
to secondhand smoke, dietary factors (collectively
known as PrimeScreen [13], a brief 18-item diet assessment), use of vitamin supplements, physical activity, high blood pressure, diabetes, total cholesterol
level, and family history of heart disease.
Each individual’s 10-year relative risk (RR) for developing CHD, compared to an average person of the same
age and sex, is estimated using the following equation:

RRl1  RRl2  …  RR1n
½ðP 1  RRC1 Þ þ ð1−P 1 Þ  1:0  ½ðP 2  RRC2 Þ þ ð1−P 2 Þ  1:0  …½ðP n  RRCn Þ þ ð1−Pn Þ  1:0
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In this equation, RRln refers to the individual’s assigned
relative risk (RR) for each risk factor, RRCn refers to the
consensus-based relative risk for that risk factor, and Pn
refers to the estimated U.S. population prevalence for
that risk factor (See Table 1) [19]. In other words, the
YDR equation uses data on each individual’s unique set
of risk factors to estimate their relative risk of developing CHD over the next 10 years, compared to another
person of the same age and sex in the general population. Each individual’s relative risk is estimated based on
the consensus-based relative risk for each of their risk
factors, as well as the prevalence of that risk factor in
the U.S. general population. Based on the estimated
YDR relative risk score calculated from this equation,
each individual is then classified into one of seven relative risk categories, ranging from “very much below
average risk” (estimated RR ≤ 0.2) to “very much above
average risk” (estimated RR > 5.1) (5). For a sample calculation using the YDR equation, see Additional file 1.
Outcomes

The outcome of interest was incident coronary heart disease (CHD), defined as fatal or nonfatal myocardial infarction (MI), occurring between return of the 1994
questionnaire and the end of follow-up on June 1,
2004. As previously stated, we chose 1994 through
2004 as the follow-up period for this analysis due to
the availability of risk factor information as well as
the age distribution of NHS participants. Nonfatal MI
was confirmed using World Health Organization criteria along with a positive electrocardiogram test or
elevated cardiac enzyme levels [15]. Data on deaths
were collected via reports from next of kin, the postal
service, and the National Death Index. Fatal MI cases
were confirmed by patient medical records, autopsy
reports, or death certificates [15].
Assessment of risk factors

Information on risk factors in the study population was
obtained from participants’ responses on the 1994 questionnaire or as close to 1994 as possible. Studies have
validated self-reported data in the NHS [20–22]. Pearson
correlations for measured versus self-reported values
were 0.59 for physical activity, 0.94 for height, and 0.97
for weight; Pearson correlations for dietary factors
ranged from 0.25–0.61 for intake of fruits, 0.30–0.47 for
intake of vegetables, 0.58-0.79 for intake of whole grains,
and was 0.41–0.59 for intake of fats (including saturated
fat, trans fat and unsaturated fat) [20–22]. Previous studies also have demonstrated the validity of the shortened
diet assessment, PrimeScreen [13], which is used in
YDR. We re-coded all of the variables from the NHS
data to be as consistent as possible with the risk factor
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definitions and categories that are used in the YDR tool
(see Additional file 2 for details).
The YDR tool was specifically designed to use selfreported risk factor information at one point in time to
estimate relative risk of developing CHD over the next
10 years. It does this based on self-reported information
at a single point in time and does not update this information over time. Therefore, although updated risk factor information is available for participants in the NHS,
we only used participants’ risk factor information as of
1994 for this analysis, in order to be consistent with how
the YDR tool was intended to be used.
Statistical analysis

We examined the observed prevalences of each risk factor in the NHS study population in 1994 and compared
them to the estimated U.S. prevalences used in the YDR
relative risk calculation. We then fit a series of logistic
regression models with CHD as the outcome, first including each individual risk factor in a separate model
and then including all of the individual risk factors in
the same multivariate model, and compared the observed RRs for each risk factor in the study population
to the consensus-based RRs used in the YDR relative
risk calculation.
To examine the predictive ability of the YDR tool,
we then fit a logistic regression model including indicator variables for the YDR relative risk categories as
predictors of CHD. We assessed the calibration of the
tool by comparing the observed RRs for each relative
risk category in the study population to the estimated
YDR relative risk category. To assess the discriminatory accuracy of the tool, we examined the area
under the curve (AUC, or c-statistic) for the logistic
regression model including indicator variables for the
YDR relative risk categories and calculated 95 % confidence intervals for the c-statistics, overall and within
5-year age groups [23]. To evaluate the performance
of the YDR tool in younger and older women, we
used the Rosner and Glynn approach to compare the
c-statistics of the model in women <60 years old and
in women ≥ 60 years old [24].
We performed all statistical analyses using SAS version
9.3 (SAS Institute, Inc, Cary, NC).

Results
The final study population for this analysis included
55,802 women, 97.9 % white, who were aged 47 to 74 in
1994. Women who were included were slightly younger
than those who were excluded (mean age = 60.5 years
versus 61.2 years). During the 10-year follow-up period,
there were 1165 cases of incident CHD among women
who were included in the study population (2.1 %). The
10-year risk of CHD was slightly higher among women
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Table 1 Comparison of observed prevalences of Your Disease Risk (YDR) risk factors with estimated U.S. population prevalences and
observed relative risks of coronary heart disease with consensus–based relative risks among 55,802 Nurses’ Health Study (NHS)
participants, 1994–2004
Risk factor

Observed prevalence
of risk factor in NHS

Estimated U.S.
population
prevalence

N (%)

%

Observed unadjusted
RR(95 % CI) in NHS

Observed multivariate
RR(95 % CI) in NHS a

Consensus–
based RR

Overweight/Obesity
BMI < 25 kg/m2 (Age < 60)

12,022 (44.3)

50.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

BMI ≥ 25– <29 kg/m2 (Age < 60)

7480 (27.5)

20.0

1.21 (0.88–1.65)

1.02 (0.74–1.40)

2.25

BMI ≥ 29 kg/m (Age < 60)

7664 (28.2)

30.0

2.10 (1.60–2.75)

1.47 (1.09–1.97)

5.00

Waist ≤ 35in (Age ≥ 60)

24,381(85.1)

54.7

1.00 (REF)

1.00 (REF)

1.00 (REF)

Waist > 35in (Age ≥ 60)

4255 (14.9)

45.3

1.47 (1.24–1.74)

1.23 (1.03–1.46)

2.25

2

Smoking status
Current smoker, ≥25 cig/day

1068 (1.9)

5.0

2.12 (1.50–2.98)

2.73 (1.92–3.89)

5.00

Current smoker, 15–24 cig/day

2552 (4.6)

10.0

2.48 (1.99–3.09)

3.15 (2.50–3.97)

2.25

Current smoker, ≤ 14 cig/day

2762 (5.0)

9.0

2.61 (2.12–3.21)

3.13 (2.51–3.89)

1.30

Past smoker, quit <2 years ago

1078 (1.9)

6.0

1.80 (1.25–2.60)

1.84 (1.27–2.67)

1.30

Past smoker, quit 2– < 10 years
ago

5439 (9.8)

6.0

1.44 (1.18–1.76)

1.44 (1.17–1.76)

1.30

Past smoker, quit 10– < 20 years
ago

5934 (10.6)

6.0

1.10 (0.89–1.36)

1.13 (0.91–1.40)

1.00

Past smoker, quit ≥20 years ago

11,673 (20.9)

10.0

1.11 (0.94–1.31)

1.09 (0.92–1.29)

1.00

Never smoked

25,296 (45.3)

48.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

37,614 (67.4)

90.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

18,188 (32.6)

10.0

1.03 (0.91–1.16)

1.20 (1.04–1.37)

1.30

≥5 times/week

23,497 (42.1)

60.0

1.01 (0.89–1.13)

1.02 (0.91–1.15)

0.80

<5 times/week

32,305 (57.9)

40.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥3 hours/week

11,870 (21.3)

19.0

0.79 (0.68–0.92)

0.85 (0.73–1.00)

0.55

<3 hours/week

43,932 (78.7)

81.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

Yes

14,227 (25.5)

27.5

2.05 (1.83–2.31)

1.51 (1.33–1.71)

2.25

No

41,575 (74.5)

72.5

1.00 (REF)

1.00 (REF)

1.00 (REF)

Yes

2180 (3.9)

8.1

4.41 (3.72–5.22)

3.20 (2.67–3.83)

2.25

No

53,622 (96.1)

91.9

1.00 (REF)

1.00 (REF)

1.00 (REF)

≤159

3960(7.1)

14.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

160–199

14,062 (25.2)

35.0

0.83 (0.63–1.09)

0.86 (0.66–1.13)

1.30

200–239

26,693 (47.8)

30.0

1.15 (0.90–1.47)

0.98 (0.76–1.26)

2.25

240–299

9542 (17.1)

15.0

1.48 (1.14–1.93)

1.26 (0.96–1.65)

5.00

≥300

1545 (2.8)

6.0

2.56 (1.83–3.58)

2.00 (1.43–2.82)

7.00

18,234 (32.7)

46.0

1.43 (1.27–1.60)

1.30 (1.15–1.46)

2.25

Exposure to secondhand smoke
(past and never smokers)b
Almost never or occasionally
exposed
Regularly exposed
Multivitamin or B complex

Physical activity

High blood pressurec

Diabetes or high blood sugar

Total cholesterol leveld

Family history of heart disease
Yes
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Table 1 Comparison of observed prevalences of Your Disease Risk (YDR) risk factors with estimated U.S. population prevalences and
observed relative risks of coronary heart disease with consensus–based relative risks among 55,802 Nurses’ Health Study (NHS)
participants, 1994–2004 (Continued)
No

37,568 (67.3)

54.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥2 servings/week

13,961 (25.0)

35.0

0.91 (0.79–1.05)

0.90 (0.78–1.04)

0.55

<2 servings/week

41,841 (75.0)

65.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

Fish

Fruits and vegetables
≥5 servings/day

31,966 (57.3)

26.0

1.08 (0.96–1.21)

1.11 (0.98–1.26)

0.55

<5 servings/day

23,836 (42.7)

74.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥3 servings/day

3605 (6.5)

11.0

0.83 (0.64–1.07)

0.79 (0.61–1.03)

0.55

<3 servings/day

52,197 (93.5)

89.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

e

Foods containing whole grains

Nuts
≥3 servings/week

13,077 (23.4)

12.0

1.06 (0.93–1.21)

0.99 (0.86–1.13)

0.80

<3 servings/week

42,725 (76.6)

88.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥2 servings/day

14,079 (25.2)

71.0

1.18 (1.03–1.34)

1.08 (0.95–1.24)

1.30

<2 servings/day

41,723 (74.8)

29.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥5 servings/week

35,222 (63.1)

40.0

1.04 (0.92–1.18)

1.00 (0.89–1.14)

1.30

<5 servings/week

20,580 (36.9)

60.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥5 servings/week

21,565 (38.7)

15.0

0.91 (0.80–1.02)

0.94 (0.83–1.06)

0.80

<5 servings/week

34,237 (61.4)

85.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

f

Foods containing saturated fat

Foods containing trans fatg

h

Foods containing unsaturated fat

Alcohol
none

47,038 (84.3)

89.0

1.00 (REF)

1.00 (REF)

1.00 (REF)

≥1drink/day

8764 (15.7)

11.0

0.82 (0.69–0.97)

0.79 (0.66–0.94)

0.55

REF reference group, RR relative risk, CI confidence interval, BMI Body Mass Index
a
Multivariate RRs are adjusted for all risk factors in table
b
Observed prevalences and estimated US population prevalences do not include current smokers
c
Those who indicated they were on high blood pressure medication were coded in the “yes” category
d
Those who indicated “high cholesterol” without specifying a specific level and those who were on statins were coded in the “200–239” category
e
Exposed group defined as those who ate 3or more servings a day of oats, cereal, cooked cereal, dark bread, brown rice, other grains, bran, popcorn, oat bran or
wheat germ. YDR whole grain question text, “Do you eat 3 or more servings of whole grains per day (wheat bread, whole grain pasta, brown rice, oatmeal, whole
grain breakfast cereal, bran or popcorn)?
f
Exposed group defined as those who ate 2 or more servings a day of whole milk, butter, cream cheese, lard, red meat, cottage cheese, and other cheese. YDR
saturated fat question text, “Do you usually eat butter, lard, red meat, cheese, or whole milk 2 or more times per day?”
g
Exposed group defined as those who ate 5 or more servings per week of margarine, vegetable shortening, fried food, store–bought baked goods (pies, sweet
rolls, cakes, cookies, donuts, or brownies). YDR trans fat question text, “Do you eat stick margarine, vegetable shortening, store–bought baked goods (cookies,
cakes, pies) or deep–fried fast food on most days?”
h
Exposed group defined as those who ate 5 or more servings per week of olive oil or vegetable oil. YDR unsaturated fat question text, “Do you eat oil–based
salad dressing or use liquid vegetable oil for cooking on most days?”

who were excluded (3.3 %), which is not surprising given
that one of main reasons for exclusion was a prior history of heart disease.
The observed prevalences of the YDR risk factors in
the study population and the estimated U.S. population
prevalences are shown in Table 1. The observed prevalences of some risk factors in the study population (e.g.
physical activity, high blood pressure, and alcohol intake)
were similar to the estimated U.S. prevalences, although
others were somewhat different. For example, over 57 %

of NHS study participants reported eating at least 5
servings of fruits and vegetables a day, compared to the
estimated U.S. population prevalence of 26 %. Study participants also reported lower intake of foods containing
saturated fat and higher intake of foods containing unsaturated fat and trans fat, compared to the population
U.S. population estimates.
Table 1 also shows the observed RRs for each of the
YDR risk factors in the study population and the
consensus-based RRs. The observed RRs for some of the
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risk factors, such as obesity and smoking status, were
weaker than the consensus-based RRs. However, most of
the observed associations were in the expected direction
and were fairly similar in magnitude to the consensusbased RRs.
The observed relative risks for CHD according to estimated YDR relative risk category are shown in Table 2.
Although the observed RRs for each category were
closer to 1 than the estimated RRs, the observed RRs did
increase monotonically with increasing YDR category.
Participants in the lower YDR relative risk categories
had lower CHD risk compared to participants in the
“average” YDR relative risk category; for example, the
age-adjusted RR for participants in the “very much
below average risk” category was 0.43 (95 % CI: 0.33,
0.56). Participants in the higher YDR relative risk categories had higher CHD risk compared to participants
in the “average” YDR relative risk category; the ageadjusted RR for participants in the “very much above
average risk” category was 2.48 (95 % CI: 1.68, 3.67).
When we examined the mean age within each of the

estimated YDR relative risk categories, we found that
participants in the two highest YDR relative risk categories were slightly younger than participants in the other
categories (data not shown), leading to confounding by
age; this explains why adjusting for age led to changes in
the observed relative risks. The results were similar
when the analyses were stratified by age, although the
observed RRs were slightly closer to the estimated YDR
relative risk categories among participants who were
younger than age 60 in 1994.
Table 3 displays the c-statistics for the logistic regression model with indicator variables for the YDR relative
risk categories. The unadjusted c-statistic among all participants was 0.62 (95 % CI: 0.60–0.63), but this increased with adjustment for age; the age-adjusted cstatistic among all participants was 0.71 (95 % CI: 0.69,
0.72). When the analyses were stratified by age, the YDR
relative risk category model had better discriminatory
accuracy in younger age groups; the c-statistic was 0.71
(95 % CI: 0.69, 0.74) for those age 55 and younger,
whereas it was 0.59 (95 % CI: 0.58, 0.61) for those over

Table 2 Observed relative risks of coronary heart disease according to estimated Your Disease Risk (YDR) relative risk category
among 55,802 Nurses’ Health Study participants, 1994–2004, overall and stratified by age in 1994
N (%)

No. cases (total = 1165)

Observed RR (95 % CI)a

Age–adjusted RR(95 % CI)b

Very much below average (RR ≤ 0.2)

23,140 (41.5)

290

0.42 (0.32–0.55)

0.43 (0.33–0.56)

Much below average (0.2 < RR ≤ 0.5)

14,941 (26.8)

308

0.70 (0.53–0.91)

0.68 (0.52–0.89)

Below average (0.5 < RR ≤ 0.9)

7278 (13.0)

173

0.81 (0.61–1.07)

0.78 (0.59–1.04)

Estimated YDR relative risk category

About average (0.9 < RR ≤ 1.1)

2321 (4.2)

68

1.00 (REF)

1.00 (REF)

Above average (1.1 < RR ≤ 2.1)

4369 (7.8)

166

1.31 (0.98–1.74)

1.32 (0.99–1.76)

Much above average (2.1 < RR ≤ 5.1)

2836 (5.1)

115

1.40 (1.03–1.90)

1.55 (1.14–2.11)

Very much above average (RR > 5.1)

917 (1.6)

45

1.71 (1.16–2.51)

2.48 (1.68–3.67)

Very much below average (RR ≤ 0.2)

11,390 (41.9)

56

0.39 (0.22–0.71)

0.40 (0.22–0.71)

Much below average (0.2 < RR ≤ 0.5)

6923 (25.5)

62

0.72 (0.40–1.29)

0.71 (0.40–1.28)

Below average (0.5 < RR ≤ 0.9)

3271 (12.0)

38

0.94 (0.51–1.73)

0.93 (0.50–1.72)

Age < 60 (N = 27,166)

About average (0.9 < RR ≤ 1.1)

1129 (4.2)

14

1.00 (REF)

1.00 (REF)

Above average (1.1 < RR ≤ 2.1)

2156 (7.9)

47

1.78 (0.97–3.24)

1.73 (0.95–3.15)

Much above average (2.1 < RR ≤ 5.1)

1586 (5.8)

40

2.06 (1.12–3.81)

2.01 (1.09–3.72)

Very much above average (RR > 5.1)

711 (2.6)

26

3.02 (1.57–5.83)

2.97 (1.54–5.74)

Very much below average (RR ≤ 0.2)

11,750 (41.0)

234

0.43 (0.32–0.58)

0.43 (0.32–0.59)

Much below average (0.2 < RR ≤ 0.5)

8018 (28.0)

246

0.67 (0.49–0.90)

0.67 (0.50–0.91)

Below average (0.5 < RR ≤ 0.9)

4007 (14.0)

135

0.74 (0.53–1.01)

0.74 (0.54–1.02)

Age ≥60 (N = 28,636)

About average (0.9 < RR ≤ 1.1)

1192 (4.2)

54

1.00 (REF)

1.00 (REF)

Above average (1.1 < RR ≤ 2.1)

2213 (7.7)

119

1.20 (0.86–1.67)

1.20 (0.87–1.67)

Much above average (2.1 < RR ≤ 5.1)

1250 (4.4)

75

1.35 (0.94–1.93)

1.40 (0.98–2.00)

Very much above average (RR > 5.1)

206 (0.7)

19

2.14 (1.24–3.69)

2.27 (1.32–3.93)

REF reference group, RR relative risk, CI confidence interval
a
Logistic regression model includes indicator variables representing YDR relative risk categories
b
Logistic regression model includes indicator variables representing YDR relative risk categories, and adjusts for age as a continuous variable
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Table 3 Discriminatory accuracy for models with Your Disease Risk (YDR) relative risk category among 55,802 Nurses’ Health Study
participants, 1994–2004, overall and stratified by age in 1994
N

No. cases

YDR relative risk category model:a

C–statistic (95 % CI):

0.62 (0.60–0.63)

Age–adjusted c–statistic (95 % CI):

0.71 (0.69–0.72)

Age–specific c–statistic (95 % CI):
≤55:

14,918

124

0.71 (0.69–0.74)

56–60:

12,469

160

0.66 (0.65–0.68)

61–65:

11,350

244

0.62 (0.61–0.64)

66–70:

11,222

386

0.62 (0.61–0.64)

>70:

5843

251

0.59 (0.58–0.61)

RR relative risk, C-statistic concordance statistic, CI confidence interval
a
YDR relative risk category model contains indicator variables representing the YDR risk categories (Very much below average (RR ≤ 0.2), Much below average (0.2
< RR ≤ 0.5), Below average (0.5 < RR ≤ 0.9), About average (0.9 < RR ≤ 1.1), Above average (1.1 < RR ≤ 2.1), Much above average (2.1 < RR ≤ 5.1), Very much above
average (RR > 5.1))

age 70. The c-statistics for the YDR relative risk category
model among women who were less than age 60 and
among women who were 60 or older were significantly
different from one another (p = 0.001).

Discussion
The purpose of this study was to evaluate the validity of
the Your Disease Risk tool for estimating 10-year relative
risk of CHD among middle-aged women. Since the YDR
parameters were developed by a consensus-based
process, this study represents an independent evaluation
of the tool’s performance. Overall, our results show that
YDR had moderate discriminatory accuracy in this
population, as reflected by the unadjusted c-statistic, although the fit of the model improved substantially with
adjustment for age. The YDR tool also seemed to perform better among the younger than the older women
in this population.
Other validation studies of CHD risk prediction tools
have had similar results as our study [6, 8, 9, 11, 12, 25].
For example, c-statistics for the Framingham model for
predicting 5-year risk of CHD in an ethnically diverse
population have ranged from 0.40 to 0.83 [23]. It is important to note that the Framingham model includes age
and estimates absolute risk, while YDR does not include
age and instead estimates an individual’s relative risk
compared to someone of the same age and sex [5]. The
discriminatory accuracy of the Framingham model was
lower when evaluated in an older population (median
age = 73), with c-statistics of 0.58 for both women and
men [26]. These findings are fairly consistent with our
results, since YDR also showed better discrimination in
the younger than the older age groups. This may be
because age is a more important risk factor for CHD in
older individuals, whereas lifestyle factors may be more
important in younger individuals and their role may
lessen with age [25, 27–29].

In another recent paper that examined the validity of
different cardiovascular risk prediction models in various
populations, the original Framingham risk prediction algorithm for CHD had a c-statistic of 0.68 and the Adult
Treatment Panel III risk prediction tool had a c-statistic
of 0.71 in a multi-ethnic cohort of men and women aged
50–74 years [30]. Again, these values are similar to the
c-statistics that were observed for the YDR tool in our
study population. Viewed as a whole, these results indicate that the YDR tool – which uses only simple, selfreported risk factor information – has similar discriminatory ability as other CHD risk assessment tools that
utilize more detailed clinical information.
Our study has several important strengths. The study
population was large and was assembled from a wellestablished cohort with detailed information on many
lifestyle and clinical risk factors. Our outcome of interest
(CHD) was confirmed by medical records, rather than
including self-reported diagnoses [15]. Unlike most other
validated CHD risk prediction tools, YDR includes modifiable risk factors and only requires information that can
be easily self-reported by patients (such as diet, physical
activity, and general clinical risk factors). We calculated
participants’ YDR relative risk scores as they would be
calculated in a real-world setting; data from one point in
time (1994 or as close to 1994 as possible) was used to
calculate the YDR relative risk score over the next
10 years, and risk factor information was not updated
over time. This is consistent with how the YDR tool was
intended to be use.
Our study also has some limitations. We excluded a
large number of women, which reduced the sample size
and could affect the generalizability of our results. In
addition, our study population included only nurses,
who may be different than women in the general population. Although some studies have suggested that higher
levels of education may be associated with healthier
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lifestyle choices and a more favorable cardiovascular risk
factor profile [31], restriction of our study population to
nurses does not imply that the results are only applicable
to nurses. The YDR tool assigns a consensus-based relative risk to each risk factor that is included. In general,
studies have shown similar associations between dietary
and lifestyle factors and risk of chronic diseases, including CHD and cancer, in the NHS population and in
other groups of women [32, 33]. Furthermore, the 10year risk of CHD in our study population was 2.1 %,
which is similar to other cohorts of women. For example, in a multi-racial cohort of middle-aged women in
the Atherosclerosis Risk in Communities study, the observed risk of CHD was 1.9 % over 9.2 years of followup [34]. In a cohort of Danish women who were aged
30-63 at the beginning of the study, the 10-year risk of
CHD was approximately 2 % [35]. These results show
that the incidence of CHD in our cohort was fairly comparable to other groups of women.
In addition, the observed relative risks for the YDR
categories generally were less strong than the relative
risks estimated by the tool. This indicates that the YDR
tool may not be well-calibrated in this population, especially in the extreme risk categories; it overestimated the
risk in the lower categories, and underestimated the risk
in the higher categories. In reality, the calibration of the
YDR tool, as well as other risk prediction models, may
depend on the distribution of risk factors in the population of interest.
Another limitation is that all of the risk factors were
self-reported via mailed questionnaires, which could potentially lead to misclassification. However, several studies have shown that self-reported data on weight, height,
waist circumference, physical activity, and dietary factors
are valid in this cohort [20–22]; furthermore, YDR was
designed specifically to utilize only information that can
be easily reported by patients or the general public. Our
findings do show that the observed RRs for some of the
YDR risk factors in our study were different than the
consensus-based RRs and different than in previous analyses in the NHS population. For example, the observed
RR for CHD was 0.99 comparing intake of ≥ 3 servings/
day of nuts vs. <3 servings/day, while a previous NHS
analysis showed a strong inverse association for intake
of nuts [36]. Similarly, the observed RR for CHD was
1.00 comparing those who consumed foods containing
trans fat ≥5 times/week versus <5 times/week, whereas
trans fat intake has been associated with elevated CHD
risk in other NHS analyses [37]. There are several possible explanations for these differences. First, many of
the variables are not assessed in the same way on
the YDR tool and on the NHS questionnaires
(see
Additional file 2 for a side by side comparison of
YDR and NHS variable categories). In particular, the
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questions about intake of certain foods that are used
in the YDR tool are far less detailed than the food
frequency questionnaires that are used to assess nutritional intake in the NHS. As a result, there is
likely to be much more misclassification of dietary
factors based on the YDR tool than in other NHS
analyses, which would lead to attenuation of the observed associations. We also used information on dietary
and other risk factors from only one point in time and did
not update it over the course of the 10-year follow-up
period, whereas other NHS analyses do update risk factor
data over time; we performed the analysis in this manner
to be consistent with how the YDR tool incorporates information on lifestyle and dietary factors. In addition, the
observed RRs for the YDR risk factors in our study are for
10-year risk of CHD, while the consensus-based RRs refer
to lifetime risk of CHD. Finally, with changing standards
of care in the U.S., the impact of dietary and lifestyle factors on risk of CHD may have changed since the development of the YDR tool.

Conclusion
In summary, the YDR tool appears to have moderate validity for estimating 10-year relative risk of CHD in this
population of middle-aged women and to be comparable
to other CHD risk prediction tools. Further research
should aim to improve the performance of the tool and
to examine its validity in other populations.
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variable categories side by side. (PDF 188 kb)
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